Eric Feldman
Geen lopende functies
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Peter van Vlasselaer | M | 64 |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | 5 jaar |
| peter vlasselaer | M | - |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | 6 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Franklin Berger | M | 74 | 10 jaar | |
| John McLaughlin | M | 72 | 9 jaar | |
| John Orwin | M | 62 | 9 jaar | |
| Kirk D. Schumacher | M | - | 11 jaar | |
| Jean Liu | F | 55 | 9 jaar | |
| Christopher Boerner | M | 53 | 5 jaar | |
| Dennis Benjamin | M | - | 3 jaar | |
| Naomi Hunder | M | 54 | 7 jaar | |
| Leslie Aberman | F | - | 8 jaar | |
| Stanford Peng | M | 53 | 1 jaar | |
| Brandi Robinson | F | - | 2 jaar | |
| David Fontana | M | - | - | |
| Robert Lechleider | M | - | 4 jaar | |
| Elizabeth Bekiroglu | F | 54 | 5 jaar | |
| Eric Sievers | M | 60 | 9 jaar | |
| Florian Fischer | M | 56 |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | - |
| Tina Albertson | M | 51 | 5 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 19 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Eric Feldman
- Persoonlijk netwerk